Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.04 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |